Xtx Topco LTD Affimed N.V. Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.32 - $0.62 $6,323 - $12,252
19,762 New
19,762 $12,000
Q1 2023

May 12, 2023
BUY
$0.66 - $1.29 $23,758 - $46,437
35,998 New
35,998 $26,000
Q3 2022

Nov 14, 2022
BUY
$1.96 - $3.32 $64,866 - $109,875
33,095 New
33,095 $68,000
Q1 2022

May 13, 2022
SELL
$3.69 - $5.65 $80,220 - $122,831
-21,740 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$5.37 - $7.07 $116,743 - $153,701
21,740 New
21,740 $120,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $185M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email